valproic acid has been researched along with n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Cui, W; He, X; Jia, Y; Wang, L; Xiang, Z; Zhang, Y | 1 |
2 other study(ies) available for valproic acid and n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism.
Topics: Animals; Atrophy; Autistic Disorder; Autophagy; Beclin-1; Behavior, Animal; Cerebellum; Dendritic Spines; Dipeptides; Disease Models, Animal; Disks Large Homolog 4 Protein; Female; Hippocampus; Male; Microtubule-Associated Proteins; Phosphorylation; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Receptor, Notch1; Sequestosome-1 Protein; Signal Transduction; Valproic Acid | 2019 |